To create this model, Vanderbilt and GE analyzed and linked immunotherapy treatment responses of cancer patients from the health system in order to train the model to identify outcomes and likelihood of adverse reactions for patients.
The AI model was tested and was able to predict patients’ responses to immunotherapies with 70% to 80% accuracy, according to a March 4 news release from GE.
The organizations say based on the study, the model has the potential for wide deployment.
“We aim to partner with pharmaceutical companies, researchers, and clinicians to optimize and ultimately apply the AI models in therapy development and in clinical practice,” Jan Wolber, global product leader — digital at GE HealthCare’s pharmaceutical diagnostics segment, said in the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
